High number of hospitalisations and non-classical presentations: lessons learned from a measles outbreak in 2017, Belgium | Epidemiology & Infection | Cambridge Core
Belgium to stop giving Oxford/AstraZeneca vaccine to people under 56 – POLITICO
Sera from different age cohorts in Belgium show limited cross-neutralization between the mumps vaccine and outbreak strains - Clinical Microbiology and Infection
Vaccines | Free Full-Text | Measles Virus Infection and Immunity in a Suboptimal Vaccination Coverage Setting | HTML
Het vaccindilemma: is het individuele risico op bijwerkingen belangrijker, of het algemeen belang?
De situatie in België in 2016 - Vax Info
Preventive care - For a Healthy Belgium
France measles outbreak: babies hit hardest - VaccinesToday
Nuvaxovid alternatief voor mensen die niet tegen Covid-19 konden gevaccineerd worden | Zorgnet-Icuro
Belgian minister tweets EU's Covid vaccine price list to anger of manufacturers | Coronavirus | The Guardian
Preventive care - For a Healthy Belgium
Belgium to give booster coronavirus vaccines for immunocompromised – POLITICO
Measles Vaccination: Current Targets May Not Be Enough To Accomplish Elimination | Technology Networks
SciELO - Saúde Pública - Towards elimination: measles susceptibility in Australia and 17 European countries Towards elimination: measles susceptibility in Australia and 17 European countries
Safety and immunogenicity of the measles vector-based SARS-CoV-2 vaccine candidate, V591, in adults: results from a phase 1/2 randomised, double-blind, placebo-controlled, dose-ranging trial - eBioMedicine
Vaccines | Free Full-Text | Risk of Absence of Measles Antibody in Healthcare Personnel and Efficacy of Booster Vaccination | HTML
Preventive care - For a Healthy Belgium
Why has France not yet eliminated measles? - VaccinesToday
Prevalence of Measles Antibodies in São José do Rio Preto, São Paulo, Brazil: A serological survey model | Scientific Reports
Preventive care - For a Healthy Belgium
Seroprevalence of measles, mumps, and rubella and genetic characterization of mumps virus in Khartoum, Sudan - International Journal of Infectious Diseases
Monthly measles and rubella monitoring report, May 2019
References in Protection against varicella with two doses of combined measles-mumps-rubella-varicella vaccine versus one dose of monovalent varicella vaccine: a multicentre, observer-blind, randomised, controlled trial - The Lancet
Belgium - Traveler view | Travelers' Health | CDC
